Kopran Ltd
Kopran Ltd Company History
Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).
2003
Receives approval from the patent office of the US for its new chemical entity (NCE), KNC-6
Received an approval for restructuring its high cost debts from the Corporate Debt Restructuring (CDR) Cell. The key highlights of this restructuring is as follows:
1. The rates of interest both on long term debts and the working capital borrowing would come down from the current 13.50% to 9% leading to significant reduction of the interest cost.
2. The repayments of long-term debts have been rescheduled to be paid by 2009.
3. Release of additional working capital to meet requirements of the planned growth in business.
HSBC Financial Services has acquired a 6.06 per cent stake in Kopran Pharmaceuticals, taking its holding in the Mumbai-based pharmaceutical company to 10.01 per cent.
Kopran receives approval from EDQM for its API facility at Mahad
2003
2004
Kopran Ltd has informed that The Stock Exchange Ahmedabad (ASE) vide letter dated April 08, 2004 have delisted the shares of the Company w.e.f. April 08, 2004.
Merrill Lynch Capital Markets Espana SA SV, has acquired an 8.49 per cent stake in drug maker Kopran through the open market
Kopran Ltd has informed that at the meeting of the BoD of the company held on July 31, 2004, Board has recorded and accepted the resignation of Mr. Tapan Ray, Managing Director of the company with effect from October 31, 2004
2004
2005
The Company has appointed Mr.H.P.Vyas as Company Secretary.
The Company has entered into a Strategic Alliance with Merck Specialities Pvt Ltd.
2005
2006
The company has signed a distribution pact with Mumbai-based Manish Pharma for its complete range of over the counter (OTC) products.
2006
2011
The company has appointed Mr. Abhinav Mathur as a Company Secretary & Compliance Officer.
2011
2013
Kopran Ltd. is launching a new brand "SPARKLE" in the FMCG category.The first product which would be launched would be Toothpaste, followed by various other products".
2013
2018
"Kopran Research Laboratories Limited, a wholly owned subsidiary of the Company purchased API facility at Panoli , Gujarat".
2018
